TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 88 filers reported holding TRINITY BIOTECH PLC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $170,000 | -0.6% | 24,591 | +67.4% | 0.01% | -9.1% |
| Q1 2016 | $171,000 | +6.2% | 14,691 | +7.1% | 0.01% | +37.5% |
| Q4 2015 | $161,000 | -46.3% | 13,713 | -19.9% | 0.01% | -61.9% |
| Q4 2014 | $300,000 | -38.5% | 17,119 | -19.2% | 0.02% | -4.5% |
| Q2 2014 | $488,000 | +54.9% | 21,200 | +63.1% | 0.02% | 0.0% |
| Q1 2014 | $315,000 | +56.7% | 13,000 | +62.5% | 0.02% | +37.5% |
| Q4 2013 | $201,000 | -17.6% | 8,000 | -44.8% | 0.02% | -44.8% |
| Q2 2013 | $244,000 | – | 14,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |